Emory University Hospital Midtown — Atlanta, Georgia

Public research footprint of Emory University Hospital Midtown, compiled from the ClinicalTrials.gov public registry.

465

Registered studies

251

Active

124

Recruiting now

149

Completed

Stopped or withdrawn

Most-studied conditions

Endometrial Dedifferentiated Carcinoma · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · Endometrial Clear Cell Adenocarcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Emory University Hospital Midtown?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.